Julie Christensen

Group Leader Cell Biology at Cellerant Therapeutics - San Carlos, California, United States

Julie Christensen's Contact Details
HQ
Location
San Carlos,California,United States
Company
Cellerant Therapeutics
Julie Christensen's Company Details
Cellerant Therapeutics logo, Cellerant Therapeutics contact details

Cellerant Therapeutics

San Carlos, California, United States • 5 Employees
Research

Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant's romyelocel-L is a universal cell therapy which does not require HLA matching intended to prevent bacterial and fungal infections during neutropenia. In a randomized, controlled Phase 2 clinical trial in AML patients, romyelocel-L reduced infections and days in hospital. Cellerant is developing two novel antibody drug-conjugate (ADC) products: CLT030 to treat AML by selectively targeting and killing leukemic stem and blast cells, and CSC012-ADC for hematologic malignancies and solid tumor indications.

Details about Cellerant Therapeutics
Frequently Asked Questions about Julie Christensen
Julie Christensen currently works for Cellerant Therapeutics.
Julie Christensen's role at Cellerant Therapeutics is Group Leader Cell Biology.
Julie Christensen's email address is ***@. To view Julie Christensen's full email address, please signup to ConnectPlex.
Julie Christensen works in the Research industry.
Julie Christensen's colleagues at Cellerant Therapeutics are Trang Nguyen, Luqman Gbenro, Myralee Martinez, Helen Gebremicael, Chitra Saraiya, Lane Welton, Shailaja Police and others.
Julie Christensen's phone number is
See more information about Julie Christensen